Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gilead Sciences

117.41
+1.371.18%
Pre-market: 117.36-0.0500-0.04%04:19 EDT
Volume:14.41M
Turnover:1.69B
Market Cap:146.22B
PE:308.97
High:118.42
Open:115.65
Low:114.79
Close:116.04
Loading ...

24H|Super Micro Jumps 7%; Upstart Soars 27%; Firefly Neuroscience Surges Another 18% After Soaring 171%

Tiger Newspress
·
12 Feb

Gilead (GILD) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks
·
12 Feb

Gilead's HIV Segment Buoying Product Sales Amid Covid Losses -- Market Talk

Dow Jones
·
12 Feb

Gilead Sciences (GILD) Tops Q4 Earnings and Revenue Estimates

Zacks
·
12 Feb

Gilead Sciences Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
12 Feb

Gilead Sciences (GILD) Q4 2024 Earnings: EPS of $1.42 Beats Estimates, Revenue Surpasses Expectations at $7.6 Billion

GuruFocus
·
12 Feb

Stock Track | Gilead Sciences Soars 5.32% After Hours on Strong Q4 Results, Upbeat Outlook

Stock Track
·
12 Feb

Gilead Sciences Q4 Non-GAAP Earnings, Revenue Rise -- Shares Up After Hours

MT Newswires Live
·
12 Feb

Gilead Sciences (NASDAQ:GILD) Delivers Strong Q4 Numbers

StockStory
·
12 Feb

Gilead: Q4 Earnings Snapshot

Associated Press Finance
·
12 Feb

BRIEF-Gilead Sciences Announces Fourth Quarter And Full Year 2024 Financial Results

Reuters
·
12 Feb

BRIEF-Gilead Sciences Announces 2.6 Percent Increase In First Quarter 2025 Dividend

Reuters
·
12 Feb

Gilead Sciences Inc - Quarterly Dividend Increased to $0.79 per Share

THOMSON REUTERS
·
12 Feb

Gilead Sciences Announces 2.6 Percent Increase in First Quarter 2025 Dividend

THOMSON REUTERS
·
12 Feb

Gilead quarterly results beat estimates

Reuters
·
12 Feb

Gilead Sciences Q4 2024 Adj. EPS $1.90 Beats $1.70 Estimate, Sales $7.569B Beat $7.137B Estimate

Benzinga
·
12 Feb